Point of Care Applications
Dermaflow technology for Home and Clinic
Dermaflow technology (DF) has been validated in the measurement of peripheral blood flow in a variety of clinical applications, including peripheral artery disease (PAD).
Recent pilot clinical work has confirmed earlier trials in demonstrating the ability of the technology to differentiate between PAD-affected and healthy lower limbs.
In this trial, lower limb peripheral blood flow was stimulated using Transcutaneous Electrical Nerve Stimulation (TENS), which is a known effect of this technology.
The advantages of a TENS-DF combination are evident in a variety of point-of-care lower limb peripheral blood flow applications, including:
(1) Mobility compromised individuals: research in PAD patients over 65 years of age has shown that lower limb pain in the largest barrier to increasing mobility.
- A TENS with Dermaflow Inside™ (TENS-DF) would offer patients the ability to increase mobility accompanied by a technology which:
- will monitor their progress,
- feedback the information
- facilitate modulation and automation where blood flow is stimulated only when necessary
(2) PAD screening
- The TENS-DF combination will allow simple non-invasive screening of asymptomatic individuals, as is shown in the above chart. There is clear difference between peripheral blood flow in PAD-affected and healthy lower limbs..
(3) Self-monitoring of lower limb peripheral blood flow, for both asymptomatic and PAD affected patients.
- Increasing sedentary lifestyles increase the risk of PAD
“In a large population-based study, higher levels of physical activity were independently associated with lower odds of vascular disease in the lower extremities and carotid arteries”
- Use of a TENS-DF can decrease the user probability for development of pre-symptomatic PAD.
- PAD-diagnosed patients would be able to track the their conditions in their homes towards disease maintenance and improvement.